Cargando…
OA03.13. Clinical evaluation of Amrutadhya Guggulu & Lekhana Basti in Medodushti with special reference to Dyslipidaemia
PURPOSE: Cardiovascular diseases (CVD) are the major cause of morbidity and mortality in our society with Dyslipidaemia contributing significantly to atherosclerosis. All components of Dyslipidaemia get the most attention because of the link between plasma lipids & CVD, as it is major risk facto...
Autores principales: | Vinayak, F Ashwini, Manohar, I Nilesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4147506/ http://dx.doi.org/10.4103/0257-7941.123851 |
Ejemplares similares
-
OA01.05. Role of prabhakara vati and lekhana basti treatment in the management of coronary artery disease (Hridroga)
por: Sharma, Amit Kumar, et al.
Publicado: (2012) -
Assessment of Lekhana Basti in the management of hyperlipidemia
por: Auti, Swapnil S., et al.
Publicado: (2013) -
Evaluation of anti-hyperlipidemic activity of Lekhana Basti in albino rats
por: Swapnil, S. Auti, et al.
Publicado: (2013) -
OA03.06. A clinical study to evaluate the efficacy of amritadya guggulu on elevated lipid profile.
por: Bhat, U Ajay
Publicado: (2013) -
An experimental study to evaluate the pharmacokinetic aspect of Lekhana Basti (Emaciating/ Desiccating Medicated Enema)
por: Auti, Swapnil S, et al.
Publicado: (2011)